65
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial

, , , &
Pages 179-186 | Published online: 07 Feb 2014

References

  • RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
  • DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
  • WilkinsonTMPatelISWilksMDonaldsonGCWedzichaJAAirway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316781090109512684248
  • O’DonnellRAPeeblesCWardJARelationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPDThorax2004591083784215454648
  • KanazawaHHirataKYoshikawaJAccelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patientsChest2003123259659912576384
  • StănescuDSannaAVeriterCAirways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophilsThorax19965132672718779129
  • TuratoGZuinRMiniatiMAirway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysemaAm J Respir Crit Care Med2002166110511012091179
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
  • BanerjeeDKhairOAHoneybourneDImpact of sputum bacteria on airway inflammation and health status in clinical stable COPDEur Respir J200423568569115176680
  • BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
  • PatelISSeemungalTAWilksMLloyd-OwenSJDonaldsonGCWedzichaJARelationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax200257975976412200518
  • PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
  • WhiteAJGompertzSBayleyDLResolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisThorax200358868068512885984
  • HillATCampbellEJHillSLBayleyDLStockleyRAAssociation between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitisAm J Med2000109428829510996579
  • MarinAMonsóEGarcia-NuñezMVariability and effects of bronchial colonisation in patients with moderate COPDEur Respir J201035229530219643939
  • PavordIDSterkPJHargreaveFEClinical applications of assessment of airway inflammation using induced sputumEur Respir J Suppl20023740s43s12361362
  • PizzichiniEPizzichiniMMEfthimiadisAIndices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurementsAm J Respir Crit Care Med19961542 Pt 13083178756799
  • BrightlingCEMonterioWGreenRHInduced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatabilityRespir Med20019512999100211778799
  • Health Protection AgencyInvestigation of bronchoalveolar lavage, sputum and associated specimensNational Standard Method BSOP 57 Issue 2.3|| Available from: http//www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317132860548Accessed on November 12, 2013
  • PyeAStockleyRAHillSLSimple method for quantifying viable bacterial numbers in sputumJ Clin Pathol19954887197247560197
  • StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest200011761638164510858396
  • StockleyRAHillATHillSLCampbellEJBronchial inflammation: its relationship to colonizing microbial load and alpha(1)-antitrypsin deficiencyChest20001175 Suppl 1291S293S10843958
  • StockleyRAHillSLMorrisonHMEffect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical stateThorax19843964144196611601
  • SethiSJonesPWTheronMSPULSE Study groupPulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialRespir Res2010111020109213
  • AlbertRKConnettJBaileyWCCOPD Clinical Research NetworkAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
  • LodeHAlleweltMRole of newer fluoroquinolones in lower respiratory tract infectionsJ Antimicrob Chemother200249570971212003962
  • TakizawaHDesakiMOhtoshiTErythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cellsAm J Respir Crit Care Med199715612662719230759
  • KadirTIzzetinFVCevikbasşAJohanssonCBClarkPIn vitro effects of clarithromycin on human polymorphonuclear leukocyte functionsChemotherapy200046319820310765036
  • WilsonRAllegraLHuchonGMOSAIC Study GroupShort-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitisChest2004125395396415006954
  • WilsonRAnzuetoAMiravitllesMMoxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsEur Respir J2012401172722135277